z-logo
open-access-imgOpen Access
Plasma Endothelin Concentrations in Hypertension
Author(s) -
Jane Goddard,
David J. Webb
Publication year - 2000
Publication title -
journal of cardiovascular pharmacology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/00005344-200000002-00007
Subject(s) - endothelins , endothelin receptor , vasoconstriction , paracrine signalling , endocrinology , medicine , endothelium , endothelin 1 , pathophysiology of hypertension , blood pressure , receptor
The endothelins comprise a family of potent vasoconstricting peptides. Endothelin-1 appears to be the predominant isoform produced by the vascular endothelium, acting mainly in a paracrine fashion on vascular smooth muscle cells to cause vasoconstriction. It also has a range of other local actions--in the kidney, in the nervous system and on other hormone systems--that could, potentially, play a part in the genesis of hypertension. The association of raised plasma endothelin concentrations in human hypertension has caused much interest, but the literature is not consistent. Given the generally low plasma concentration of the endothelins, and their mainly paracrine actions, it remains unclear whether plasma endothelin has a functional role in hypertension. Additionally, problems remain with the measurement of plasma endothelin that raise doubts about the validity of conclusions drawn from these measurements.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here